Skip to main content
. 2022 Oct 8;23(19):11939. doi: 10.3390/ijms231911939

Figure 7.

Figure 7

Figure 7

Values of predicted concentrations with and without PK interaction for (a) siremadlin and (b) trametinib in spleen tissue; (c) siremadlin and (d) trametinib in A375 tumour tissue; observed data are means from n = 3.